Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 1/2016

Ausgabe 1/2016

Inhaltsverzeichnis ( 12 Artikel )

01.01.2016 | Original Article | Ausgabe 1/2016

Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells

Philipp Müller, Sacha I. Rothschild, Walter Arnold, Petra Hirschmann, Lukas Horvath, Lukas Bubendorf, Spasenija Savic, Alfred Zippelius

01.01.2016 | Original Article | Ausgabe 1/2016

Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesis

Mia Shapiro, Bisweswar Nandi, Christine Pai, Mehmet K. Samur, Dheeraj Pelluru, Mariateresa Fulciniti, Rao H. Prabhala, Nikhil C. Munshi, Jason S. Gold

01.01.2016 | Original Article | Ausgabe 1/2016

A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites

Craig L. Slingluff Jr, Gina R. Petroni, Walter C. Olson, Mark E. Smolkin, Kimberly A. Chianese-Bullock, Ileana S. Mauldin, Kelly T. Smith, Donna H. Deacon, Nikole E. Varhegyi, Sean B. Donnelly, Caroline M. Reed, Kristy Scott, Nadejda V. Galeassi, William W. Grosh

01.01.2016 | Original Article | Ausgabe 1/2016

Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients

Danay Saavedra, Beatriz García, Patricia Lorenzo-Luaces, Amnely González, Xitlally Popa, Karla P. Fuentes, Zaima Mazorra, Tania Crombet, Elia Neninger, Agustin Lage

01.01.2016 | Original Article | Ausgabe 1/2016

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

Francisco Javier Carretero, Ana Belen del Campo, Jose Francisco Flores-Martín, Rosa Mendez, Cesar García-Lopez, Jose Manuel Cozar, Victoria Adams, Stephen Ward, Teresa Cabrera, Francisco Ruiz-Cabello, Federico Garrido, Natalia Aptsiauri

01.01.2016 | Original Article | Ausgabe 1/2016

Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions

Hye-Jin Hong, Hui Xuan Lim, Ju Han Song, Arim Lee, Eugene Kim, Daeho Cho, Edward P. Cohen, Tae Sung Kim

01.01.2016 | Original Article | Ausgabe 1/2016

Low intratumoral regulatory T cells and high peritumoral CD8+ T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy

Li Liu, Guochao Zhao, Wenchuan Wu, Yefei Rong, Dayong Jin, Dansong Wang, Wenhui Lou, Xinyu Qin

01.01.2016 | Original Article | Ausgabe 1/2016

Phloretin increases the anti-tumor efficacy of intratumorally delivered heat-shock protein 70 kDa (HSP70) in a murine model of melanoma

Sergey V. Abkin, Olga S. Ostroumova, Elena Y. Komarova, Darya A. Meshalkina, Maxim A. Shevtsov, Boris A. Margulis, Irina V. Guzhova

01.01.2016 | Focussed Research Review | Ausgabe 1/2016

Developments in cancer vaccines for hepatocellular carcinoma

Luigi Buonaguro, HEPAVAC Consortium

01.01.2016 | Focussed Research Review | Ausgabe 1/2016

Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies

Gaetano Finocchiaro, Serena Pellegatta

01.01.2016 | Focussed Research Review | Ausgabe 1/2016

Cholesterol metabolites and tumor microenvironment: the road towards clinical translation

Laura Raccosta, Raffaella Fontana, Gianfranca Corna, Daniela Maggioni, Marta Moresco, Vincenzo Russo

01.01.2016 | Meeting Report | Ausgabe 1/2016

“Cancer Bio-Immunotherapy in Siena”: Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9–11, 2014

Michele Maio, Erica Bertocci, Lorenzo Pilla, Carolina Fazio, Carla Chiarucci, Ornella Cutaia, Ester Fonsatti, Cristina Maccalli, Giorgio Parmiani, NIBIT

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise